Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Developing Topics Session - Developing Topics in Phase 1 and Phase 2 Clinical Trials
  • Developing Topics Session
  • Amyloid-related Imaging Abnormalities In A Phase 1 Study Of Mivelsiran In Patients With Early-onset Alzheimer’s Disease
  • ICC Auditorium
    Set Timezone

Neal S. Parikh1, Sharon Cohen2, Lynn Farrugia1, Julia Shirvan1, Weizhi Zhao1, Steven M. Greenberg3.
1Alnylam Pharmaceuticals Inc., Cambridge, MA, USA, 2Toronto Memory Program, Toronto, ON, USA, 3Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Types
Main Session